ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||||||||||||||||||||
zinc dichloride
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
multiple interactions | EXP | 7 | 87,133,179 | 87,342,639 | RGD:6480464 | CTD | |
| G | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
multiple interactions | ISO | 7 | 87,133,179 | 87,342,639 | RGD:6480464 | CTD | |
| G | ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
|
multiple interactions | EXP | 2 | 220,074,488 | 220,083,712 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
multiple interactions | ISO | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACO2 | aconitase 2, mitochondrial |
|
multiple interactions | EXP | 22 | 41,865,129 | 41,924,993 | RGD:6480464 | CTD | |
| G | ADAM2 | ADAM metallopeptidase domain 2 |
|
decreases expression | EXP | 8 | 39,601,254 | 39,695,779 | RGD:6480464 | CTD | |
| G | ADM | adrenomedullin |
|
multiple interactions | EXP | 11 | 10,326,642 | 10,328,923 | RGD:6480464 | CTD | |
| G | ADORA1 | adenosine A1 receptor |
|
multiple interactions | ISO | 1 | 203,096,836 | 203,136,533 | RGD:6480464 | CTD | |
| G | AFP | alpha-fetoprotein |
|
decreases expression | EXP | 4 | 74,301,933 | 74,321,492 | RGD:6480464 | CTD | |
| G | AGO2 | argonaute RISC catalytic component 2 |
|
multiple interactions | EXP | 8 | 141,541,264 | 141,645,646 | RGD:6480464 | CTD | |
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation | ISO | 14 | 105,235,686 | 105,262,080 | RGD:6480464 | CTD | |
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions | ISO | 14 | 105,235,686 | 105,262,080 | RGD:6480464 | CTD | |
| G | ALAD | aminolevulinate dehydratase |
|
multiple interactions | ISO | 9 | 116,148,592 | 116,163,618 | RGD:6480464 | CTD | |
| G | ALDOA | aldolase A, fructose-bisphosphate |
|
multiple interactions | EXP | 16 | 30,064,411 | 30,081,741 | RGD:6480464 | CTD | |
| G | ALDOC | aldolase C, fructose-bisphosphate |
|
multiple interactions | EXP | 17 | 26,900,133 | 26,903,951 | RGD:6480464 | CTD | |
| G | ALPL | alkaline phosphatase, liver/bone/kidney |
|
multiple interactions | ISO | 1 | 21,835,858 | 21,904,905 | RGD:6480464 | CTD | |
| G | ANG | angiogenin, ribonuclease, RNase A family, 5 |
|
multiple interactions | EXP | 14 | 21,152,336 | 21,162,345 | RGD:6480464 | CTD | |
| G | ANGPTL4 | angiopoietin-like 4 |
|
multiple interactions | EXP | 19 | 8,429,011 | 8,439,257 | RGD:6480464 | CTD | |
| G | ANKRD37 | ankyrin repeat domain 37 |
|
multiple interactions | EXP | 4 | 186,317,840 | 186,321,390 | RGD:6480464 | CTD | |
| G | ANKZF1 | ankyrin repeat and zinc finger domain containing 1 |
|
multiple interactions | EXP | 2 | 220,094,479 | 220,101,391 | RGD:6480464 | CTD | |
| G | AR | androgen receptor |
|
multiple interactions | ISO | X | 66,763,874 | 66,950,461 | RGD:6480464 | CTD | |
| G | ARG2 | arginase, type II |
|
increases expression | EXP | 14 | 68,086,579 | 68,118,437 | RGD:6480464 | CTD | |
| G | ARRB2 | arrestin, beta 2 |
|
affects localization | EXP | 17 | 4,613,789 | 4,624,795 | RGD:6480464 | CTD | |
| G | ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) |
|
decreases expression | EXP | 22 | 39,916,569 | 39,918,691 | RGD:6480464 | CTD | |
| G | ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 |
|
decreases expression | EXP | 8 | 20,054,704 | 20,079,207 | RGD:6480464 | CTD | |
| G | ATP7B | ATPase, Cu++ transporting, beta polypeptide |
|
decreases expression | EXP | 13 | 52,506,805 | 52,585,630 | RGD:6480464 | CTD | |
| G | ATP7B | ATPase, Cu++ transporting, beta polypeptide |
|
increases expression | EXP | 13 | 52,506,805 | 52,585,630 | RGD:6480464 | CTD | |
| G | BAG3 | BCL2-associated athanogene 3 |
|
increases expression | EXP | 10 | 121,410,882 | 121,437,331 | RGD:6480464 | CTD | |
| G | BAG3 | BCL2-associated athanogene 3 |
|
increases expression | EXP | 10 | 121,410,882 | 121,437,331 | RGD:6480464 | CTD | |
| G | BAG3 | BCL2-associated athanogene 3 |
|
multiple interactions | EXP | 10 | 121,410,882 | 121,437,331 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | EXP | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
multiple interactions | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BBC3 | BCL2 binding component 3 |
|
multiple interactions | ISO | 19 | 47,724,079 | 47,736,023 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
multiple interactions | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2A1 | BCL2-related protein A1 |
|
increases expression | EXP | 15 | 80,253,232 | 80,263,643 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
multiple interactions | EXP | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BGLAP | bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions | ISO | 1 | 156,211,951 | 156,213,123 | RGD:6480464 | CTD | |
| G | BGLAP | bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions | ISO | 1 | 156,211,951 | 156,213,123 | RGD:6480464 | CTD | |
| G | BHLHE40 | basic helix-loop-helix family, member e40 |
|
multiple interactions | EXP | 3 | 5,021,097 | 5,026,866 | RGD:6480464 | CTD | |
| G | BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like |
|
multiple interactions | EXP | 8 | 26,240,523 | 26,270,644 | RGD:6480464 | CTD | |
| G | BOP1 | block of proliferation 1 |
|
multiple interactions | EXP | 8 | 145,486,056 | 145,515,120 | RGD:6480464 | CTD | |
| G | C3 | complement component 3 |
|
increases expression | EXP | 19 | 6,677,846 | 6,720,662 | RGD:6480464 | CTD | |
| G | CA13 | carbonic anhydrase XIII |
|
increases expression | ISO | 8 | 86,157,716 | 86,196,302 | RGD:6480464 | CTD | |
| G | CA9 | carbonic anhydrase IX |
|
multiple interactions | EXP | 9 | 35,673,915 | 35,681,156 | RGD:6480464 | CTD | |
| G | CALD1 | caldesmon 1 |
|
increases expression | EXP | 7 | 134,464,164 | 134,655,480 | RGD:6480464 | CTD | |
| G | CASP12 | caspase 12 (gene/pseudogene) |
|
multiple interactions | EXP | 11 | 104,756,445 | 104,769,397 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases activity | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases expression | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CCDC102B | coiled-coil domain containing 102B |
|
increases expression | EXP | 18 | 66,382,491 | 66,722,426 | RGD:6480464 | CTD | |
| G | CCL11 | chemokine (C-C motif) ligand 11 |
|
increases expression | EXP | 17 | 32,612,687 | 32,615,199 | RGD:6480464 | CTD | |
| G | CCL15 | chemokine (C-C motif) ligand 15 |
|
decreases expression | EXP | 17 | 34,324,618 | 34,329,084 | RGD:6480464 | CTD | |
| G | CCL17 | chemokine (C-C motif) ligand 17 |
|
decreases expression | EXP | 16 | 57,438,679 | 57,449,974 | RGD:6480464 | CTD | |
| G | CCL19 | chemokine (C-C motif) ligand 19 |
|
decreases expression | EXP | 9 | 34,689,567 | 34,691,274 | RGD:6480464 | CTD | |
| G | CCL20 | chemokine (C-C motif) ligand 20 |
|
increases expression | EXP | 2 | 228,678,558 | 228,682,280 | RGD:6480464 | CTD | |
| G | CCL20 | chemokine (C-C motif) ligand 20 |
|
increases expression | EXP | 2 | 228,678,558 | 228,682,280 | RGD:6480464 | CTD | |
| G | CCL24 | chemokine (C-C motif) ligand 24 |
|
decreases expression | EXP | 7 | 75,441,114 | 75,443,033 | RGD:6480464 | CTD | |
| G | CCL26 | chemokine (C-C motif) ligand 26 |
|
increases expression | EXP | 7 | 75,398,842 | 75,419,064 | RGD:6480464 | CTD | |
| G | CCNB1 | cyclin B1 |
|
increases expression | ISO | 5 | 68,462,837 | 68,474,072 | RGD:6480464 | CTD | |
| G | CCNG1 | cyclin G1 |
|
multiple interactions | ISO | 5 | 162,864,577 | 162,872,022 | RGD:6480464 | CTD | |
| G | CCNG2 | cyclin G2 |
|
multiple interactions | EXP | 4 | 78,078,357 | 78,091,213 | RGD:6480464 | CTD | |
| G | CCR6 | chemokine (C-C motif) receptor 6 |
|
decreases expression | EXP | 6 | 167,525,295 | 167,552,629 | RGD:6480464 | CTD | |
| G | CCR8 | chemokine (C-C motif) receptor 8 |
|
decreases expression | EXP | 3 | 39,371,197 | 39,375,171 | RGD:6480464 | CTD | |
| G | CD9 | CD9 molecule |
|
increases expression | EXP | 12 | 6,309,482 | 6,347,437 | RGD:6480464 | CTD | |
| G | CDH17 | cadherin 17, LI cadherin (liver-intestine) |
|
decreases expression | EXP | 8 | 95,139,394 | 95,229,531 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions | EXP | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
decreases expression | EXP | 12 | 12,870,302 | 12,875,305 | RGD:6480464 | CTD | |
| G | CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression | EXP | 9 | 22,002,902 | 22,009,312 | RGD:6480464 | CTD | |
| G | CDR1 | cerebellar degeneration-related protein 1, 34kDa |
|
decreases expression | EXP | X | 139,865,425 | 139,866,723 | RGD:6480464 | CTD | |
| G | CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
|
increases expression | EXP | 19 | 42,259,398 | 42,276,113 | RGD:6480464 | CTD | |
| G | CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
|
increases expression | EXP | 7 | 117,120,017 | 117,308,719 | RGD:6480464 | CTD | |
| G | CHEK1 | checkpoint kinase 1 |
|
increases expression | ISO | 11 | 125,495,031 | 125,546,150 | RGD:6480464 | CTD | |
| G | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions | EXP | 6 | 139,693,392 | 139,695,787 | RGD:6480464 | CTD | |
| G | COL1A1 | collagen, type I, alpha 1 |
|
multiple interactions | ISO | 17 | 48,261,457 | 48,279,000 | RGD:6480464 | CTD | |
| G | COL1A1 | collagen, type I, alpha 1 |
|
multiple interactions | ISO | 17 | 48,261,457 | 48,279,000 | RGD:6480464 | CTD | |
| G | COX17 | cytochrome c oxidase assembly homolog 17 (yeast) |
|
decreases expression | EXP | 3 | 119,388,372 | 119,396,243 | RGD:6480464 | CTD | |
| G | CP | ceruloplasmin (ferroxidase) |
|
increases expression | EXP | 3 | 148,880,197 | 148,939,832 | RGD:6480464 | CTD | |
| G | CPS1 | carbamoyl-phosphate synthase 1, mitochondrial |
|
increases expression | EXP | 2 | 211,342,406 | 211,543,831 | RGD:6480464 | CTD | |
| G | CRP | C-reactive protein, pentraxin-related |
|
increases expression | EXP | 1 | 159,682,079 | 159,684,379 | RGD:6480464 | CTD | |
| G | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression | EXP | 5 | 131,409,485 | 131,411,863 | RGD:6480464 | CTD | |
| G | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions | ISO | 5 | 131,409,485 | 131,411,863 | RGD:6480464 | CTD | |
| G | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression | ISO | 5 | 131,409,485 | 131,411,863 | RGD:6480464 | CTD | |
| G | CSRP2 | cysteine and glycine-rich protein 2 |
|
multiple interactions | EXP | 12 | 77,252,496 | 77,272,799 | RGD:6480464 | CTD | |
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression | EXP | 4 | 74,735,109 | 74,737,019 | RGD:6480464 | CTD | |
| G | CXCL11 | chemokine (C-X-C motif) ligand 11 |
|
increases expression | EXP | 4 | 76,954,835 | 76,957,350 | RGD:6480464 | CTD | |
| G | CXCL13 | chemokine (C-X-C motif) ligand 13 |
|
decreases expression | EXP | 4 | 78,432,907 | 78,532,988 | RGD:6480464 | CTD | |
| G | CXCL14 | chemokine (C-X-C motif) ligand 14 |
|
increases expression | EXP | 5 | 134,906,369 | 134,914,969 | RGD:6480464 | CTD | |
| G | CXCL5 | chemokine (C-X-C motif) ligand 5 |
|
increases expression | EXP | 4 | 74,861,359 | 74,864,416 | RGD:6480464 | CTD | |
| G | CXCL6 | chemokine (C-X-C motif) ligand 6 |
|
decreases expression | EXP | 4 | 74,702,273 | 74,704,477 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases stability | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | DCP1B | DCP1 decapping enzyme homolog B (S. cerevisiae) |
|
multiple interactions | EXP | 12 | 2,055,214 | 2,113,677 | RGD:6480464 | CTD | |
| G | DDX21 | DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
multiple interactions | EXP | 10 | 70,715,879 | 70,744,825 | RGD:6480464 | CTD | |
| G | DHRS2 | dehydrogenase/reductase (SDR family) member 2 |
|
increases expression | EXP | 14 | 24,105,573 | 24,114,848 | RGD:6480464 | CTD | |
| G | DICER1 | dicer 1, ribonuclease type III |
|
multiple interactions | EXP | 14 | 95,552,565 | 95,623,759 | RGD:6480464 | CTD | |
| G | DRD1 | dopamine receptor D1 |
|
multiple interactions | ISO | 5 | 174,867,675 | 174,871,163 | RGD:6480464 | CTD | |
| G | DRD2 | dopamine receptor D2 |
|
multiple interactions | ISO | 11 | 113,280,317 | 113,346,001 | RGD:6480464 | CTD | |
| G | DROSHA | drosha, ribonuclease type III |
|
multiple interactions | EXP | 5 | 31,400,601 | 31,532,282 | RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
increases phosphorylation | EXP | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGLN1 | egl nine homolog 1 (C. elegans) |
|
multiple interactions | EXP | 1 | 231,499,497 | 231,560,790 | RGD:6480464 | CTD | |
| G | EGLN1 | egl nine homolog 1 (C. elegans) |
|
multiple interactions | EXP | 1 | 231,499,497 | 231,560,790 | RGD:6480464 | CTD | |
| G | EIF4E | eukaryotic translation initiation factor 4E |
|
multiple interactions | EXP | 4 | 99,799,607 | 99,851,786 | RGD:6480464 | CTD | |
| G | ELK1 | ELK1, member of ETS oncogene family |
|
multiple interactions | ISO | X | 47,494,919 | 47,510,003 | RGD:6480464 | CTD | |
| G | ELK1 | ELK1, member of ETS oncogene family |
|
increases activity | ISO | X | 47,494,919 | 47,510,003 | RGD:6480464 | CTD | |
| G | EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 |
|
multiple interactions | ISO | 19 | 6,887,560 | 6,940,464 | RGD:6480464 | CTD | |
| G | EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 |
|
increases expression | ISO | 19 | 6,887,560 | 6,940,464 | RGD:6480464 | CTD | |
| G | ENO2 | enolase 2 (gamma, neuronal) |
|
multiple interactions | EXP | 12 | 7,023,614 | 7,032,859 | RGD:6480464 | CTD | |
| G | EPO | erythropoietin |
|
multiple interactions | EXP | 7 | 100,318,423 | 100,321,323 | RGD:6480464 | CTD | |
| G | F2RL2 | coagulation factor II (thrombin) receptor-like 2 |
|
decreases expression | EXP | 5 | 75,911,307 | 75,919,259 | RGD:6480464 | CTD | |
| G | FABP1 | fatty acid binding protein 1, liver |
|
decreases expression | EXP | 2 | 88,422,501 | 88,427,650 | RGD:6480464 | CTD | |
| G | FAM162A | family with sequence similarity 162, member A |
|
multiple interactions | EXP | 3 | 122,103,023 | 122,128,961 | RGD:6480464 | CTD | |
| G | FASN | fatty acid synthase |
|
decreases expression | EXP | 17 | 80,036,214 | 80,056,106 | RGD:6480464 | CTD | |
| G | FOS | FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions | EXP | 14 | 75,745,481 | 75,748,937 | RGD:6480464 | CTD | |
| G | FOSL1 | FOS-like antigen 1 |
|
increases expression | ISO | 11 | 65,659,692 | 65,667,997 | RGD:6480464 | CTD | |
| G | FOXA2 | forkhead box A2 |
|
decreases expression | EXP | 20 | 22,561,642 | 22,566,101 | RGD:6480464 | CTD | |
| G | FOXD1 | forkhead box D1 |
|
increases expression | EXP | 5 | 72,742,083 | 72,744,352 | RGD:6480464 | CTD | |
| G | G6PD | glucose-6-phosphate dehydrogenase |
|
multiple interactions | ISO | X | 153,759,606 | 153,775,787 | RGD:6480464 | CTD | |
| G | GBE1 | glucan (1,4-alpha-), branching enzyme 1 |
|
multiple interactions | EXP | 3 | 81,538,850 | 81,810,950 | RGD:6480464 | CTD | |
| G | GCLC | glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions | EXP | 6 | 53,362,139 | 53,409,927 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
multiple interactions | EXP | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GPX2 | glutathione peroxidase 2 (gastrointestinal) |
|
increases expression | EXP | 14 | 65,405,870 | 65,409,623 | RGD:6480464 | CTD | |
| G | GRIK2 | glutamate receptor, ionotropic, kainate 2 |
|
increases expression | EXP | 6 | 101,846,861 | 102,517,958 | RGD:6480464 | CTD | |
| G | GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
multiple interactions | ISO | 16 | 9,847,265 | 10,276,611 | RGD:6480464 | CTD | |
| G | GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions | ISO | 12 | 13,714,410 | 14,133,022 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | EXP | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
multiple interactions | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
multiple interactions | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GYS1 | glycogen synthase 1 (muscle) |
|
multiple interactions | EXP | 19 | 49,471,382 | 49,496,610 | RGD:6480464 | CTD | |
| G | H2AFX | H2A histone family, member X |
|
increases expression | EXP | 11 | 118,964,584 | 118,966,177 | RGD:6480464 | CTD | |
| G | HCFC1R1 | host cell factor C1 regulator 1 (XPO1 dependent) |
|
multiple interactions | EXP | 16 | 3,072,626 | 3,074,287 | RGD:6480464 | CTD | |
| G | HELLS | helicase, lymphoid-specific |
|
increases expression | ISO | 10 | 96,305,574 | 96,361,856 | RGD:6480464 | CTD | |
| G | HEPH | hephaestin |
|
decreases expression | EXP | X | 65,382,433 | 65,487,231 | RGD:6480464 | CTD | |
| G | HEXB | hexosaminidase B (beta polypeptide) |
|
multiple interactions | ISO | 5 | 73,980,969 | 74,017,113 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
affects splicing | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression | EXP | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions | ISO | 14 | 62,162,119 | 62,214,977 | RGD:6480464 | CTD | |
| G | HILPDA | hypoxia inducible lipid droplet-associated |
|
multiple interactions | EXP | 7 | 128,095,884 | 128,098,472 | RGD:6480464 | CTD | |
| G | HIPK2 | homeodomain interacting protein kinase 2 |
|
multiple interactions | EXP | 7 7 |
139,246,316 139,415,730 |
139,342,363 139,477,693 |
RGD:6480464 | CTD | |
| G | HIPK2 | homeodomain interacting protein kinase 2 |
|
multiple interactions | ISO | 7 7 |
139,246,316 139,415,730 |
139,342,363 139,477,693 |
RGD:6480464 | CTD | |
| G | HK2 | hexokinase 2 |
|
multiple interactions | EXP | 2 | 75,059,782 | 75,120,481 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HSP90AA2 | heat shock protein 90kDa alpha (cytosolic), class A member 2 |
|
increases expression | EXP | 11 | 27,909,718 | 27,912,639 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
increases expression | EXP | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA6 | heat shock 70kDa protein 6 (HSP70B') |
|
increases expression | EXP | 1 | 161,494,036 | 161,496,687 | RGD:6480464 | CTD | |
| G | HSPD1 | heat shock 60kDa protein 1 (chaperonin) |
|
increases expression | ISO | 2 | 198,351,308 | 198,364,998 | RGD:6480464 | CTD | |
| G | IFNA2 | interferon, alpha 2 |
|
decreases expression | EXP | 9 | 21,384,254 | 21,385,396 | RGD:6480464 | CTD | |
| G | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
decreases expression | EXP | 8 | 42,128,820 | 42,190,171 | RGD:6480464 | CTD | |
| G | IL10RB | interleukin 10 receptor, beta |
|
decreases expression | EXP | 21 | 34,638,665 | 34,669,539 | RGD:6480464 | CTD | |
| G | IL18R1 | interleukin 18 receptor 1 |
|
multiple interactions | EXP | 2 | 102,979,097 | 103,015,218 | RGD:6480464 | CTD | |
| G | IL1A | interleukin 1, alpha |
|
increases expression | ISO | 2 | 113,531,492 | 113,542,971 | RGD:6480464 | CTD | |
| G | IL1A | interleukin 1, alpha |
|
multiple interactions | ISO | 2 | 113,531,492 | 113,542,971 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
increases expression | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1RL1 | interleukin 1 receptor-like 1 |
|
increases expression | ISO | 2 | 102,927,962 | 102,968,497 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
increases expression | EXP | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL3 | interleukin 3 (colony-stimulating factor, multiple) |
|
multiple interactions | ISO | 5 | 131,396,347 | 131,398,896 | RGD:6480464 | CTD | |
| G | IL3 | interleukin 3 (colony-stimulating factor, multiple) |
|
increases expression | ISO | 5 | 131,396,347 | 131,398,896 | RGD:6480464 | CTD | |
| G | IL36RN | interleukin 36 receptor antagonist |
|
decreases expression | EXP | 2 | 113,816,215 | 113,822,321 | RGD:6480464 | CTD | |
| G | IL37 | interleukin 37 |
|
decreases expression | EXP | 2 | 113,670,548 | 113,676,459 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases secretion | EXP | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases secretion | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases secretion | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | INSIG2 | insulin induced gene 2 |
|
multiple interactions | EXP | 2 | 118,846,050 | 118,867,597 | RGD:6480464 | CTD | |
| G | INSR | insulin receptor |
|
increases phosphorylation | ISO | 19 | 7,112,266 | 7,294,011 | RGD:6480464 | CTD | |
| G | IREB2 | iron-responsive element binding protein 2 |
|
increases expression | EXP | 15 | 78,730,518 | 78,793,798 | RGD:6480464 | CTD | |
| G | ITGB6 | integrin, beta 6 |
|
increases expression | EXP | 2 | 160,958,233 | 161,056,590 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
increases expression | EXP | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
increases expression | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
increases expression | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUNB | jun B proto-oncogene |
|
increases expression | ISO | 19 | 12,902,310 | 12,904,125 | RGD:6480464 | CTD | |
| G | KDM3A | lysine (K)-specific demethylase 3A |
|
multiple interactions | EXP | 2 | 86,668,271 | 86,719,839 | RGD:6480464 | CTD | |
| G | KDM4B | lysine (K)-specific demethylase 4B |
|
multiple interactions | EXP | 19 | 4,969,124 | 5,153,609 | RGD:6480464 | CTD | |
| G | LEP | leptin |
|
increases expression | EXP | 7 | 127,881,331 | 127,897,682 | RGD:6480464 | CTD | |
| G | LIMCH1 | LIM and calponin homology domains 1 |
|
multiple interactions | EXP | 4 | 41,362,804 | 41,702,061 | RGD:6480464 | CTD | |
| G | LTA | lymphotoxin alpha (TNF superfamily, member 1) |
|
decreases expression | EXP | 6 | 31,539,876 | 31,542,101 | RGD:6480464 | CTD | |
| G | LTA | lymphotoxin alpha (TNF superfamily, member 1) |
|
increases expression | EXP | 6 | 31,539,876 | 31,542,101 | RGD:6480464 | CTD | |
| G | LTB4R | leukotriene B4 receptor |
|
decreases expression | EXP | 14 | 24,780,705 | 24,787,242 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
multiple interactions | EXP | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) |
|
increases expression | EXP | 17 | 79,876,145 | 79,885,587 | RGD:6480464 | CTD | |
| G | MAP2K4 | mitogen-activated protein kinase kinase 4 |
|
increases activity | ISO | 17 | 11,924,135 | 12,047,051 | RGD:6480464 | CTD | |
| G | MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 5 | 56,110,900 | 56,191,979 | RGD:6480464 | CTD | |
| G | MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
|
increases activity | ISO | 5 | 56,110,900 | 56,191,979 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
increases activity | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
increases phosphorylation | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
increases activity | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
increases phosphorylation | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
increases phosphorylation | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK8 | mitogen-activated protein kinase 8 |
|
multiple interactions | ISO | 10 | 49,609,687 | 49,643,183 | RGD:6480464 | CTD | |
| G | MAPK8 | mitogen-activated protein kinase 8 |
|
multiple interactions | ISO | 10 | 49,609,687 | 49,643,183 | RGD:6480464 | CTD | |
| G | MAPK9 | mitogen-activated protein kinase 9 |
|
multiple interactions | ISO | 5 | 179,660,594 | 179,719,071 | RGD:6480464 | CTD | |
| G | MCM3 | minichromosome maintenance complex component 3 |
|
increases expression | ISO | 6 | 52,128,812 | 52,149,679 | RGD:6480464 | CTD | |
| G | MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
decreases expression | EXP | 22 | 24,236,565 | 24,237,409 | RGD:6480464 | CTD | |
| G | MIR130A | microRNA 130a |
|
multiple interactions | EXP | 11 | 57,408,671 | 57,408,759 | RGD:6480464 | CTD | |
| G | MIR15A | microRNA 15a |
|
multiple interactions | EXP | 13 | 50,623,255 | 50,623,337 | RGD:6480464 | CTD | |
| G | MIR223 | microRNA 223 |
|
multiple interactions | EXP | X | 65,238,712 | 65,238,821 | RGD:6480464 | CTD | |
| G | MIR29A | microRNA 29a |
|
multiple interactions | EXP | 7 | 130,561,506 | 130,561,569 | RGD:6480464 | CTD | |
| G | MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
multiple interactions | EXP | 16 | 55,513,081 | 55,540,586 | RGD:6480464 | CTD | |
| G | MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) |
|
decreases expression | EXP | 11 | 102,391,239 | 102,401,478 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
affects binding | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
decreases response to substance | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
decreases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
multiple interactions | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
affects response to substance | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
multiple interactions | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
multiple interactions | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1E | metallothionein 1E |
|
increases expression | EXP | 16 | 56,659,585 | 56,661,024 | RGD:6480464 | CTD | |
| G | MT1F | metallothionein 1F |
|
increases expression | EXP | 16 | 56,691,855 | 56,693,215 | RGD:6480464 | CTD | |
| G | MT1G | metallothionein 1G |
|
increases expression | EXP | 16 | 56,700,653 | 56,701,977 | RGD:6480464 | CTD | |
| G | MT1H | metallothionein 1H |
|
increases expression | EXP | 16 | 56,703,726 | 56,705,041 | RGD:6480464 | CTD | |
| G | MT1H | metallothionein 1H |
|
increases expression | EXP | 16 | 56,703,726 | 56,705,041 | RGD:6480464 | CTD | |
| G | MT1HL1 | metallothionein 1H-like 1 |
|
increases expression | EXP | 1 | 237,167,347 | 237,167,743 | RGD:6480464 | CTD | |
| G | MT1L | metallothionein 1L (gene/pseudogene) |
|
increases expression | EXP | 16 | 56,651,373 | 56,652,730 | RGD:6480464 | CTD | |
| G | MT1M | metallothionein 1M |
|
increases expression | EXP | 16 | 56,666,534 | 56,667,898 | RGD:6480464 | CTD | |
| G | MT1X | metallothionein 1X |
|
increases expression | EXP | 16 | 56,716,382 | 56,718,108 | RGD:6480464 | CTD | |
| G | MT1X | metallothionein 1X |
|
multiple interactions | EXP | 16 | 56,716,382 | 56,718,108 | RGD:6480464 | CTD | |
| G | MT1X | metallothionein 1X |
|
increases expression | EXP | 16 | 56,716,382 | 56,718,108 | RGD:6480464 | CTD | |
| G | MT1X | metallothionein 1X |
|
increases expression | EXP | 16 | 56,716,382 | 56,718,108 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
affects binding | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
affects response to substance | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
increases expression | EXP | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MTA2 | metastasis associated 1 family, member 2 |
|
decreases expression | EXP | 11 | 62,360,675 | 62,369,312 | RGD:6480464 | CTD | |
| G | MTF1 | metal-regulatory transcription factor 1 |
|
multiple interactions | ISO | 1 | 38,275,239 | 38,325,292 | RGD:6480464 | CTD | |
| G | MTF1 | metal-regulatory transcription factor 1 |
|
affects localization | ISO | 1 | 38,275,239 | 38,325,292 | RGD:6480464 | CTD | |
| G | MTF1 | metal-regulatory transcription factor 1 |
|
decreases expression | EXP | 1 | 38,275,239 | 38,325,292 | RGD:6480464 | CTD | |
| G | MTF1 | metal-regulatory transcription factor 1 |
|
affects localization | ISO | 1 | 38,275,239 | 38,325,292 | RGD:6480464 | CTD | |
| G | MTF2 | metal response element binding transcription factor 2 |
|
decreases expression | EXP | 1 | 93,544,792 | 93,604,638 | RGD:6480464 | CTD | |
| G | NCF1 | neutrophil cytosolic factor 1 |
|
multiple interactions | ISO | 7 | 74,188,309 | 74,203,659 | RGD:6480464 | CTD | |
| G | NCF1 | neutrophil cytosolic factor 1 |
|
increases response to substance | ISO | 7 | 74,188,309 | 74,203,659 | RGD:6480464 | CTD | |
| G | NDRG1 | N-myc downstream regulated 1 |
|
multiple interactions | EXP | 8 | 134,249,414 | 134,309,547 | RGD:6480464 | CTD | |
| G | NDUFAF5 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 5 |
|
decreases expression | EXP | 20 | 13,765,672 | 13,799,067 | RGD:6480464 | CTD | |
| G | NF2 | neurofibromin 2 (merlin) |
|
decreases expression | EXP | 22 | 29,999,545 | 30,094,589 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
affects response to substance | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity | EXP | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NIP7 | NIP7, nucleolar pre-rRNA processing protein |
|
multiple interactions | EXP | 16 | 69,373,415 | 69,377,014 | RGD:6480464 | CTD | |
| G | NOX4 | NADPH oxidase 4 |
|
increases expression | EXP | 11 | 89,057,521 | 89,322,779 | RGD:6480464 | CTD | |
| G | ORM1 | orosomucoid 1 |
|
increases expression | ISO | 9 | 117,085,303 | 117,088,759 | RGD:6480464 | CTD | |
| G | ORM2 | orosomucoid 2 |
|
increases expression | ISO | 9 | 117,092,069 | 117,095,536 | RGD:6480464 | CTD | |
| G | P2RX2 | purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions | ISO | 12 | 133,195,403 | 133,198,972 | RGD:6480464 | CTD | |
| G | P4HA1 | prolyl 4-hydroxylase, alpha polypeptide I |
|
multiple interactions | EXP | 10 | 74,766,975 | 74,856,732 | RGD:6480464 | CTD | |
| G | P4HA2 | prolyl 4-hydroxylase, alpha polypeptide II |
|
multiple interactions | EXP | 5 | 131,528,303 | 131,563,556 | RGD:6480464 | CTD | |
| G | PAIP1 | poly(A) binding protein interacting protein 1 |
|
decreases expression | EXP | 5 | 43,526,369 | 43,557,521 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | EXP | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | EXP | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | ISO | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
multiple interactions | ISO | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
increases response to substance | ISO | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
increases activity | ISO | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
increases expression | ISO | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PCBD1 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha |
|
increases expression | EXP | 10 | 72,643,267 | 72,648,541 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
multiple interactions | ISO | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PDAP1 | PDGFA associated protein 1 |
|
multiple interactions | ISO | 7 | 98,992,296 | 99,006,305 | RGD:6480464 | CTD | |
| G | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 |
|
multiple interactions | EXP | 2 | 173,420,779 | 173,463,862 | RGD:6480464 | CTD | |
| G | PEG3 | paternally expressed 3 |
|
decreases expression | EXP | 19 | 57,321,445 | 57,352,094 | RGD:6480464 | CTD | |
| G | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
multiple interactions | EXP | 10 | 6,186,843 | 6,277,508 | RGD:6480464 | CTD | |
| G | PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
|
multiple interactions | EXP | 3 | 48,555,117 | 48,594,227 | RGD:6480464 | CTD | |
| G | PGF | placental growth factor |
|
increases expression | EXP | 14 | 75,408,533 | 75,422,467 | RGD:6480464 | CTD | |
| G | PGK1 | phosphoglycerate kinase 1 |
|
multiple interactions | EXP | X | 77,359,666 | 77,382,324 | RGD:6480464 | CTD | |
| G | PGM1 | phosphoglucomutase 1 |
|
multiple interactions | EXP | 1 | 64,058,947 | 64,125,916 | RGD:6480464 | CTD | |
| G | PHEX | phosphate regulating endopeptidase homolog, X-linked |
|
increases expression | ISO | X | 22,050,921 | 22,266,478 | RGD:6480464 | CTD | |
| G | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
multiple interactions | ISO | 7 | 106,505,924 | 106,547,592 | RGD:6480464 | CTD | |
| G | PIK3R4 | phosphoinositide-3-kinase, regulatory subunit 4 |
|
increases expression | EXP | 3 | 130,397,778 | 130,465,696 | RGD:6480464 | CTD | |
| G | PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 |
|
increases expression | ISO | 17 | 8,782,233 | 8,869,029 | RGD:6480464 | CTD | |
| G | PMP22 | peripheral myelin protein 22 |
|
increases expression | EXP | 17 | 15,133,096 | 15,168,644 | RGD:6480464 | CTD | |
| G | PRKCA | protein kinase C, alpha |
|
affects localization | ISO | 17 | 64,298,926 | 64,806,862 | RGD:6480464 | CTD | |
| G | PRKCA | protein kinase C, alpha |
|
multiple interactions | ISO | 17 | 64,298,926 | 64,806,862 | RGD:6480464 | CTD | |
| G | PRKCA | protein kinase C, alpha |
|
multiple interactions | ISO | 17 | 64,298,926 | 64,806,862 | RGD:6480464 | CTD | |
| G | PTH1R | parathyroid hormone 1 receptor |
|
multiple interactions | ISO | 3 | 46,919,236 | 46,945,289 | RGD:6480464 | CTD | |
| G | RAB20 | RAB20, member RAS oncogene family |
|
multiple interactions | EXP | 13 | 111,175,413 | 111,214,071 | RGD:6480464 | CTD | |
| G | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
multiple interactions | ISO | 7 | 6,414,126 | 6,443,598 | RGD:6480464 | CTD | |
| G | RAD21 | RAD21 homolog (S. pombe) |
|
increases expression | ISO | 8 | 117,858,173 | 117,887,105 | RGD:6480464 | CTD | |
| G | RAD51AP1 | RAD51 associated protein 1 |
|
increases expression | ISO | 12 | 4,647,950 | 4,669,213 | RGD:6480464 | CTD | |
| G | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 |
|
multiple interactions | ISO | 3 | 12,625,100 | 12,705,700 | RGD:6480464 | CTD | |
| G | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 |
|
increases phosphorylation | ISO | 3 | 12,625,100 | 12,705,700 | RGD:6480464 | CTD | |
| G | RANGAP1 | Ran GTPase activating protein 1 |
|
multiple interactions | EXP | 22 | 41,641,615 | 41,682,216 | RGD:6480464 | CTD | |
| G | RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
|
multiple interactions | EXP | 4 | 26,321,332 | 26,436,753 | RGD:6480464 | CTD | |
| G | RECK | reversion-inducing-cysteine-rich protein with kazal motifs |
|
multiple interactions | EXP | 9 | 36,036,910 | 36,124,452 | RGD:6480464 | CTD | |
| G | RIF1 | RAP1 interacting factor homolog (yeast) |
|
increases expression | ISO | 2 | 152,266,397 | 152,333,860 | RGD:6480464 | CTD | |
| G | RIOK3 | RIO kinase 3 |
|
multiple interactions | EXP | 18 | 21,032,787 | 21,063,101 | RGD:6480464 | CTD | |
| G | RORA | RAR-related orphan receptor A |
|
multiple interactions | EXP | 15 | 60,780,483 | 61,521,502 | RGD:6480464 | CTD | |
| G | RPL11 | ribosomal protein L11 |
|
decreases expression | EXP | 1 | 24,018,269 | 24,022,915 | RGD:6480464 | CTD | |
| G | RRP15 | ribosomal RNA processing 15 homolog (S. cerevisiae) |
|
multiple interactions | EXP | 1 | 218,458,629 | 218,511,325 | RGD:6480464 | CTD | |
| G | RRS1 | RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) |
|
multiple interactions | EXP | 8 | 67,341,263 | 67,342,968 | RGD:6480464 | CTD | |
| G | RUNX2 | runt-related transcription factor 2 |
|
multiple interactions | ISO | 6 | 45,296,054 | 45,518,819 | RGD:6480464 | CTD | |
| G | RUVBL1 | RuvB-like 1 (E. coli) |
|
multiple interactions | EXP | 3 | 127,799,800 | 127,842,671 | RGD:6480464 | CTD | |
| G | SAP30 | Sin3A-associated protein, 30kDa |
|
multiple interactions | EXP | 4 | 174,292,093 | 174,298,683 | RGD:6480464 | CTD | |
| G | SBNO1 | strawberry notch homolog 1 (Drosophila) |
|
increases expression | EXP | 12 | 123,773,656 | 123,834,988 | RGD:6480464 | CTD | |
| G | SCARA3 | scavenger receptor class A, member 3 |
|
decreases expression | EXP | 8 | 27,491,577 | 27,534,286 | RGD:6480464 | CTD | |
| G | SCARB1 | scavenger receptor class B, member 1 |
|
increases expression | ISO | 12 | 125,262,174 | 125,348,519 | RGD:6480464 | CTD | |
| G | SCD | stearoyl-CoA desaturase (delta-9-desaturase) |
|
multiple interactions | EXP | 10 | 102,106,772 | 102,124,588 | RGD:6480464 | CTD | |
| G | SELPLG | selectin P ligand |
|
increases expression | EXP | 12 | 109,015,671 | 109,027,670 | RGD:6480464 | CTD | |
| G | SERTAD2 | SERTA domain containing 2 |
|
multiple interactions | EXP | 2 | 64,858,755 | 64,881,046 | RGD:6480464 | CTD | |
| G | SLC16A3 | solute carrier family 16, member 3 (monocarboxylic acid transporter 4) |
|
multiple interactions | EXP | 17 | 80,186,282 | 80,197,375 | RGD:6480464 | CTD | |
| G | SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions | ISO | 11 | 35,272,752 | 35,441,610 | RGD:6480464 | CTD | |
| G | SLC1A5 | solute carrier family 1 (neutral amino acid transporter), member 5 |
|
decreases expression | EXP | 19 | 47,278,140 | 47,291,842 | RGD:6480464 | CTD | |
| G | SLC25A15 | solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 |
|
multiple interactions | EXP | 13 | 41,363,547 | 41,386,596 | RGD:6480464 | CTD | |
| G | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
|
multiple interactions | EXP | 1 | 43,391,046 | 43,424,847 | RGD:6480464 | CTD | |
| G | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression | ISO | 1 | 43,391,046 | 43,424,847 | RGD:6480464 | CTD | |
| G | SLC30A1 | solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions | EXP | 1 | 211,748,381 | 211,752,099 | RGD:6480464 | CTD | |
| G | SLC30A1 | solute carrier family 30 (zinc transporter), member 1 |
|
increases expression | EXP | 1 | 211,748,381 | 211,752,099 | RGD:6480464 | CTD | |
| G | SLC30A1 | solute carrier family 30 (zinc transporter), member 1 |
|
increases expression | EXP | 1 | 211,748,381 | 211,752,099 | RGD:6480464 | CTD | |
| G | SLC30A1 | solute carrier family 30 (zinc transporter), member 1 |
|
increases expression | ISO | 1 | 211,748,381 | 211,752,099 | RGD:6480464 | CTD | |
| G | SLC30A1 | solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions | ISO | 1 | 211,748,381 | 211,752,099 | RGD:6480464 | CTD | |
| G | SLC30A2 | solute carrier family 30 (zinc transporter), member 2 |
|
increases expression | ISO | 1 | 26,364,514 | 26,372,604 | RGD:6480464 | CTD | |
| G | SLC30A5 | solute carrier family 30 (zinc transporter), member 5 |
|
decreases expression | EXP | 5 | 68,389,776 | 68,426,899 | RGD:6480464 | CTD | |
| G | SLC30A5 | solute carrier family 30 (zinc transporter), member 5 |
|
multiple interactions | EXP | 5 | 68,389,776 | 68,426,899 | RGD:6480464 | CTD | |
| G | SLC30A7 | solute carrier family 30 (zinc transporter), member 7 |
|
increases expression | EXP | 1 | 101,361,632 | 101,447,311 | RGD:6480464 | CTD | |
| G | SLC30A7 | solute carrier family 30 (zinc transporter), member 7 |
|
decreases expression | EXP | 1 | 101,361,632 | 101,447,311 | RGD:6480464 | CTD | |
| G | SLC31A2 | solute carrier family 31 (copper transporters), member 2 |
|
increases expression | EXP | 9 | 115,913,238 | 115,926,422 | RGD:6480464 | CTD | |
| G | SLC31A2 | solute carrier family 31 (copper transporters), member 2 |
|
decreases expression | EXP | 9 | 115,913,238 | 115,926,422 | RGD:6480464 | CTD | |
| G | SLC39A1 | solute carrier family 39 (zinc transporter), member 1 |
|
multiple interactions | EXP | 1 | 153,931,588 | 153,940,188 | RGD:6480464 | CTD | |
| G | SLC39A2 | solute carrier family 39 (zinc transporter), member 2 |
|
multiple interactions | EXP | 14 | 21,467,414 | 21,470,034 | RGD:6480464 | CTD | |
| G | SLC39A2 | solute carrier family 39 (zinc transporter), member 2 |
|
increases expression | EXP | 14 | 21,467,414 | 21,470,034 | RGD:6480464 | CTD | |
| G | SLC39A4 | solute carrier family 39 (zinc transporter), member 4 |
|
multiple interactions | EXP | 8 | 145,637,798 | 145,642,273 | RGD:6480464 | CTD | |
| G | SLC39A4 | solute carrier family 39 (zinc transporter), member 4 |
|
decreases expression | EXP | 8 | 145,637,798 | 145,642,273 | RGD:6480464 | CTD | |
| G | SLC48A1 | solute carrier family 48 (heme transporter), member 1 |
|
increases expression | EXP | 12 | 48,166,967 | 48,176,536 | RGD:6480464 | CTD | |
| G | SLC5A1 | solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
multiple interactions | ISO | 22 | 32,439,019 | 32,509,016 | RGD:6480464 | CTD | |
| G | SLC5A2 | solute carrier family 5 (sodium/glucose cotransporter), member 2 |
|
multiple interactions | ISO | 16 | 31,494,439 | 31,502,091 | RGD:6480464 | CTD | |
| G | SLC9A1 | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
increases expression | EXP | 1 | 27,425,300 | 27,481,621 | RGD:6480464 | CTD | |
| G | SORD | sorbitol dehydrogenase |
|
multiple interactions | ISO | 15 | 45,315,302 | 45,367,287 | RGD:6480464 | CTD | |
| G | SP1 | Sp1 transcription factor |
|
multiple interactions | ISO | 12 | 53,773,979 | 53,810,230 | RGD:6480464 | CTD | |
| G | SP1 | Sp1 transcription factor |
|
increases activity | EXP | 12 | 53,773,979 | 53,810,230 | RGD:6480464 | CTD | |
| G | SP110 | SP110 nuclear body protein |
|
multiple interactions | ISO | 2 | 231,033,634 | 231,090,444 | RGD:6480464 | CTD | |
| G | SPAG4 | sperm associated antigen 4 |
|
multiple interactions | EXP | 20 | 34,203,809 | 34,208,965 | RGD:6480464 | CTD | |
| G | SPICE1 | spindle and centriole associated protein 1 |
|
decreases expression | EXP | 3 | 113,161,565 | 113,234,034 | RGD:6480464 | CTD | |
| G | SPINK1 | serine peptidase inhibitor, Kazal type 1 |
|
decreases expression | EXP | 5 | 147,204,143 | 147,211,260 | RGD:6480464 | CTD | |
| G | SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
|
multiple interactions | EXP | 5 | 136,310,987 | 136,835,018 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
decreases expression | EXP | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
multiple interactions | ISO | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
multiple interactions | ISO | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions | ISO | 20 | 35,973,088 | 36,033,821 | RGD:6480464 | CTD | |
| G | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases phosphorylation | ISO | 20 | 35,973,088 | 36,033,821 | RGD:6480464 | CTD | |
| G | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions | ISO | 20 | 35,973,088 | 36,033,821 | RGD:6480464 | CTD | |
| G | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases phosphorylation | ISO | 20 | 35,973,088 | 36,033,821 | RGD:6480464 | CTD | |
| G | SRM | spermidine synthase |
|
multiple interactions | EXP | 1 | 11,114,649 | 11,120,091 | RGD:6480464 | CTD | |
| G | ST5 | suppression of tumorigenicity 5 |
|
increases expression | EXP | 11 | 8,714,899 | 8,932,498 | RGD:6480464 | CTD | |
| G | STBD1 | starch binding domain 1 |
|
multiple interactions | EXP | 4 | 77,227,179 | 77,232,283 | RGD:6480464 | CTD | |
| G | STMN1 | stathmin 1 |
|
increases expression | ISO | 1 | 26,210,677 | 26,233,368 | RGD:6480464 | CTD | |
| G | TERT | telomerase reverse transcriptase |
|
multiple interactions | EXP | 5 | 1,253,282 | 1,295,162 | RGD:6480464 | CTD | |
| G | TF | transferrin |
|
multiple interactions | EXP | 3 | 133,464,977 | 133,497,850 | RGD:6480464 | CTD | |
| G | TF | transferrin |
|
increases expression | EXP | 3 | 133,464,977 | 133,497,850 | RGD:6480464 | CTD | |
| G | TFPI2 | tissue factor pathway inhibitor 2 |
|
increases expression | EXP | 7 | 93,514,709 | 93,520,303 | RGD:6480464 | CTD | |
| G | TFRC | transferrin receptor (p90, CD71) |
|
increases expression | ISO | 3 | 195,776,155 | 195,809,032 | RGD:6480464 | CTD | |
| G | TMEM45A | transmembrane protein 45A |
|
multiple interactions | EXP | 3 | 100,211,463 | 100,296,285 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
multiple interactions | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TRA2A | transformer 2 alpha homolog (Drosophila) |
|
decreases expression | EXP | 7 | 23,544,399 | 23,571,656 | RGD:6480464 | CTD | |
| G | TUBA1B | tubulin, alpha 1b |
|
increases expression | EXP | 12 | 49,521,565 | 49,525,304 | RGD:6480464 | CTD | |
| G | UBE2E2 | ubiquitin-conjugating enzyme E2E 2 |
|
increases expression | EXP | 3 | 23,244,784 | 23,632,296 | RGD:6480464 | CTD | |
| G | UNC5B | unc-5 homolog B (C. elegans) |
|
increases expression | EXP | 10 | 72,972,292 | 73,062,635 | RGD:6480464 | CTD | |
| G | USE1 | unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
|
increases expression | EXP | 19 | 17,326,155 | 17,330,638 | RGD:6480464 | CTD | |
| G | UTRN | utrophin |
|
affects binding | EXP | 6 | 144,612,873 | 145,174,170 | RGD:6480464 | CTD | |
| G | VEGFA | vascular endothelial growth factor A |
|
multiple interactions | EXP | 6 | 43,737,946 | 43,754,224 | RGD:6480464 | CTD | |
| G | VEGFA | vascular endothelial growth factor A |
|
multiple interactions | ISO | 6 | 43,737,946 | 43,754,224 | RGD:6480464 | CTD | |
| G | WDR4 | WD repeat domain 4 |
|
multiple interactions | EXP | 21 | 44,263,190 | 44,299,699 | RGD:6480464 | CTD | |
| G | WSB1 | WD repeat and SOCS box containing 1 |
|
multiple interactions | EXP | 17 | 25,621,106 | 25,640,645 | RGD:6480464 | CTD | |
| G | XCR1 | chemokine (C motif) receptor 1 |
|
decreases expression | EXP | 3 | 46,062,291 | 46,068,979 | RGD:6480464 | CTD | |
| G | YEATS2 | YEATS domain containing 2 |
|
multiple interactions | EXP | 3 | 183,415,606 | 183,530,413 | RGD:6480464 | CTD | |
| G | ZNF292 | zinc finger protein 292 |
|
multiple interactions | EXP | 6 | 87,865,269 | 87,973,406 | RGD:6480464 | CTD | |
Term paths to the root
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term